All Stories

  1. Enhancing Bioactive Compound Classification through the Synergy of Fourier-Transform Infrared Spectroscopy and Advanced Machine Learning Methods
  2. Predicting Cellular Rejection of Renal Allograft Based on the Serum Proteomic Fingerprint
  3. Exosomes and microvesicles in kidney transplantation: the long road from trash to gold
  4. The Characteristics and Laboratory Findings of SARS-CoV-2 Infected Patients during the First Three COVID-19 Waves in Portugal—A Retrospective Single-Center Study
  5. Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs
  6. A new methodology for a rapid and high-throughput comparison of molecular profiles and biological activity of phytoextracts
  7. Alternative Serum Biomarkers of Bacteraemia for Intensive Care Unit Patients
  8. Comparison of Analytical Methods Of Serum Untargeted Metabolomics
  9. The Impact of the Serum Extraction Protocol on Metabolomic Profiling Using UPLC-MS/MS and FTIR Spectroscopy
  10. Label-free discrimination of T and B lymphocyte activation based on vibrational spectroscopy – A machine learning approach
  11. Quality Monitoring of Biodiesel and Diesel/Biodiesel Blends: A Comparison between Benchtop FT-NIR versus a Portable Miniaturized NIR Spectroscopic Analysis
  12. Epigenetic and Drug Response Modulation of Epigalocaten-In-3-Gallate in Staphylococcus aureus with Divergent Resistance Phenotypes
  13. Plasma versus Serum Analysis by FTIR Spectroscopy to Capture the Human Physiological State
  14. Antimicrobial evaluation of the Cynara cardunculus extract in Helicobacter pylori cells using mid-infrared spectroscopy and chemometric methods
  15. Proteomics for Biomarker Discovery for Diagnosis and Prognosis of Kidney Transplantation Rejection
  16. Ovine Model as a Temporomandibular Disc Substitute: Characterisation and the Outcomes of Freezing Storage
  17. Antigenic and conserved peptides from diverse Helicobacter pylori antigens
  18. Infection Biomarkers Based on Metabolomics
  19. Development of a biocompatible hydrogel based on native temporomandibular joint extracellular matrix powder
  20. Fast identification of off‐target liabilities in early antibiotic discovery with Fourier‐transform infrared spectroscopy
  21. A new method to predict genotoxic effects based on serum molecular profile
  22. Technologies for High-Throughput Identification of Antibiotic Mechanism of Action
  23. VARIABILITY OF NEUTROPHIL-ACTIVATING PROTEIN AMONG HELICOBACTER PYLORI STRAINS
  24. Comparison of partial least squares‐discriminant analysis and soft independent modeling of class analogy methods for classification of Saccharomyces cerevisiae cells based on mid‐infrared spectroscopy
  25. Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning
  26. Potential of FTIR-Spectroscopy for Drugs Screening against Helicobacter pylori
  27. Discriminating B and T-lymphocyte from its molecular profile acquired in a label-free and high-throughput method
  28. FTIR spectroscopy applications for biomedicine
  29. A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
  30. Metabolic Fingerprinting with Fourier-Transform Infrared (FTIR) Spectroscopy: Towards a High-Throughput Screening Assay for Antibiotic Discovery and Mechanism-of-Action Elucidation
  31. A phenotypic screening bioassay forEscherichia colistress and antibiotic responses based on Fourier‐transform infrared (FTIR) spectroscopy and multivariate analysis
  32. Antibiotic Discovery: Where Have We Come from, Where Do We Go?
  33. Characterization of gastric cells infection by diverse Helicobacter pylori strains through Fourier-transform infrared spectroscopy
  34. Assessing the molecular fingerprint of T lymphocyte activation
  35. Spectral Biomarkers of Genotoxicity from Methanol Extracts of Blood
  36. Impact of the solvent extraction method on the plasma metabolome profile
  37. Classification of recombinant Saccharomyces cerevisiae cells using PLS-DA modelling based on MIR spectroscopy
  38. Effect of culturing human embryos in group on the composition of spent culture media
  39. Towards an automated statistical workflow for biomarker screening in Fourier-transform infrared spectroscopy
  40. Impact of the human mesenchymal stem cells donor on conditional medium composition
  41. Effect of consumption of green tea extracts on the plasma molecular signature
  42. Helicobacter pylori Persistence Throughout the Host Life as a High Risk of Peptic Ulcers, Gastric Cancer and MALT Lymphoma
  43. Determination of Cell Abundances and Paralytic Shellfish Toxins in Cultures of the Dinoflagellate Gymnodinium catenatum by Fourier Transform Near Infrared Spectroscopy
  44. Assessing plasmid bioprocess reproducibility and C-source uptake stage through multivariate analysis of offline and online data
  45. Comparative analysis of different transformed Saccharomyces cerevisiae strains based on high-throughput Fourier transform infrared spectroscopy
  46. High-throughput FTIR-based bioprocess analysis of recombinant cyprosin production
  47. Optimization of a bioassay to evaluate Escherichia coli stress responses
  48. Biopharmaceuticals process monitoring based on infrared spectroscopy according to Quality by Design
  49. High-throughput bioassay for mechanism of action determination of antibacterial drugs
  50. Mid-infrared spectroscopy: A groundbreaking tool for monitoring mammalian cells processes
  51. Does Nonlinear Modeling Play a Role in Plasmid Bioprocess Monitoring Using Fourier Transform Infrared Spectra?
  52. Metabolic profiling of recombinantEscherichia colicultivations based on high-throughput FT-MIR spectroscopic analysis
  53. Monitoring theex-vivoexpansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy
  54. A comprehensive high-throughput FTIR spectroscopy-based method for evaluating the transfection event: estimating the transfection efficiency and extracting associated metabolic responses
  55. In Situ Near-Infrared (NIR) versus High-Throughput Mid-Infrared (MIR) Spectroscopy to Monitor Biopharmaceutical Production
  56. Molecular fingerprint of human gastric cell line infected by Helicobacter pylori
  57. Development of a high-throughput monitoring technique of bacteria photodynamic inactivation
  58. Process Analytical Technologies in Biopharmaceutical Process Development
  59. In situ near infrared spectroscopy monitoring of cyprosin production by recombinant Saccharomyces cerevisiae strains
  60. Kinetic modeling of plasmid bioproduction in Escherichia coli DH5α cultures over different carbon-source compositions
  61. In situNIR spectroscopy monitoring of plasmid production processes: effect of producing strain, medium composition and the cultivation strategy
  62. Real-time plasmid monitoring of batch and fed-batch Escherichia coli cultures by NIR spectroscopy
  63. High-throughput analysis of the plasmid bioproduction process in Escherichia coli by FTIR spectroscopy
  64. Development and characterization of a new plasmid delivery system based on chitosan–sodium deoxycholate nanoparticles
  65. The importance of Helicobacter pylori's genetic variability for the construction of an efficient vaccine
  66. Modelling, monitoring and control of plasmid bioproduction in Escherichia coli cultures
  67. Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: In vivo evaluation
  68. A Nonionic Porphyrin as a Noninterfering DNA Antibacterial Agent
  69. Use of chemometrics in the selection of a Saccharomyces cerevisiae expression system for recombinant cyprosin B production
  70. Antigenic Diversity Among Portuguese Clinical Isolates of Helicobacter pylori
  71. Biodegradable nanoparticles of alginate and chitosan as non-viral DNA oral delivery system
  72. Monitoring bacterial processes by Fourier transform infrared spectroscopy: Helicobacter pylori drug inactivation and plasmid bioproduction in recombinant Escherichia coli cultures
  73. Optimization of the culture medium composition using response surface methodology for new recombinant cyprosin B production in bioreactor for cheese production
  74. A novel multifunctional DNA vaccine expresses conserved and immunogenic fragments of six Helicobacter pylori proteins
  75. The carbon-source on the efficiency of plasmid production in high density cultures of Escherichia coli
  76. Influence of tryptophan tags on the purification of cutinase, secreted by a recombinant Saccharomyces cerevisiae, using cationic expanded bed adsorption and hydrophobic interaction chromatography
  77. Prediction of retention time of cutinases tagged with hydrophobic peptides in hydrophobic interaction chromatography
  78. A flow injection analysis system for on‐line monitoring of cutinase activity at outlet of an expanded bed adsorption column almost in real time
  79. Micro-analytical GO/HRP bioreactor for glucose determination and bioprocess monitoring
  80. Integration of the production and the purification processes of cutinase secreted by a recombinant Saccharomyces cerevisiae SU50 strain
  81. Recombinant Saccharomyces cerevisiae strain triggers acetate production to fuel biosynthetic pathways
  82. Pressure-tuning FTIR Spectroscopy: Applications to Biomedical Research and Diagnosis
  83. Towards a cost effective strategy for cutinase production by a recombinant Saccharomyces cerevisiae: strain physiological aspects
  84. Integration of production and aqueous two-phase systems extraction of extracellular cutinase fusion proteins
  85. Development of a Fed-Batch Cultivation Strategy for the Enhanced production and Secretion of Cutinase by a Recombinant Saccharomyces cerevisiae SU50 Strain
  86. Development of a Fed-Batch Cultivation Strategy for the Enhanced Production and Secretion of Cutinase by a Recombinant Saccharomyces cerevisiae SU50 Strain
  87. Effect of Saccharomyces cerevisiae fermentation conditions on expanded bed adsorption of heterologous cutinase
  88. Optimisation of culture conditions and characterisation of cutinase produced by recombinant Saccharomyces cerevisiae
  89. Production of wild-type and peptide fusion cutinases by recombinantSaccharomyces cerevisiae MM01 strains
  90. Effect of pre-fermentation on the production of cutinase by a recombinant Saccharomyces cerevisiae